Search for: "In re: Abbott Laboratories" Results 61 - 80 of 237
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jun 2022, 12:56 pm by Bill Marler
Here are the whistleblower documents – Redacted Confidential Disclosure re Abbott Laboratories – 10-19-2021_Redacted (1) Here is the 2022 inspection report at the plant – Updated Final Applied_Unapplied Redactions Abbott Nutrition Sturgis FEI 1815692 FDA 483 1-31022 to 3-16-22 – ISSUED_Redacted Here is the complaint – abbott_complaint_0 Here is the consent decree – abbott_proposed_consent_decree_0 Please read… [read post]
25 Oct 2008, 12:03 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Biaxin (Clarithromycin) - US: New standard for materiality: Abbott Laboratories v. [read post]
6 Jun 2011, 4:58 pm by law shucks
 At the time, Daughter was a corporate associate in the Los Angeles office of a large, international law firm (the “Firm”) who was working on an impending merger and acquisition involving Abbott Laboratories (“Abbott”) and her Firm’s client, Advanced Medical Optics, Inc. [read post]
16 Jun 2010, 3:02 pm
Kappos (Patent Docs) Niaspan (Niacin) – US: Patent infringement complaint filed following a Paragraph IV certification:  Abbott Laboratories et al. v. [read post]
15 Mar 2007, 6:33 am
Abbott Laboratories, Inc., 2006 WL 3457617, *12 (D. [read post]
3 May 2007, 9:34 am
" On April 30, it editorialized again: "Earlier this month, Thailand browbeat Abbott Laboratories into reducing the price of an HIV/AIDS drug, Kaletra, by threatening to seize its patent. [read post]
28 Sep 2010, 7:14 am by Breakstone, White & Gluck
Meridia is produced by Abbott Laboratories and has been on the market since 1997. [read post]
1 Sep 2011, 2:39 am by John L. Welch
September 22, 2011 - 2 PM: Abbott Laboratories v. [read post]
29 May 2007, 5:10 am
Abbott Laboratories Inc., 444 F.3d 383 that the plaintiff there could bypass the "vaccine court" and litigate in the usual court for damages because the suit was against the makers of thimerosal, which, not being a vaccine, didn't fall under the protection of the legislation. [read post]
15 Jul 2010, 2:39 pm by Bexis
Abbott Laboratories, 607 P.2d 924 (Cal. 1980), a DES case. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas)… [read post]
15 Sep 2015, 6:17 pm
Abbott Laboratories, Inc., No. 1:13-cv-144, slip op. [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360)  … [read post]
16 Apr 2020, 8:30 am by Kimberly A. Kralowec
  Attorney Jay Lefkowitz prepared for his argument in Abbott Laboratories, the first case argued under the Supreme Court's new remote argument rules, by participating in two mock argument sessions, one by phone and one by video conference. [read post]
22 Apr 2014, 7:41 am
  Procedural HistoryThe New Drug Application (NDA) for the Tarka® product was approved by the Food and Drug Administration in 1996 and acquired by Abbott Laboratories in 2001. [read post]
6 Dec 2010, 6:06 am by Joe Consumer
" Now, here's the Times: Word quickly reached top executives at Abbott Laboratories that a Baltimore cardiologist, Dr. [read post]